Integrating data from tissue imaging, genomic databases, and clinical results could be a major key in the journey toward truly personalized medicine, according to a recent article in Genetic Engineering and Biotechnology News (found here). Careful maintenance of patient data correlated with tissue samples is one element of the best practices necessary for a truly integrated data approach to drug discovery and development.
Biopreservation and Biobanking published an article in their June edition that offers an alternative for data analysis and disclosure for biobanks. Outlined here, authors Kuiper, van den Heuvel and Swertz argue for a data analysis model that addresses privacy control issues while allowing for greater access to usable information for the support of valuable research efforts using their Statistical Disclosure Control model. This approach steps outside the more traditional methods of suppression and obfuscation.